Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004067516 | SCV002755020 | uncertain significance | not specified | 2019-12-28 | criteria provided, single submitter | clinical testing | The p.A1191V variant (also known as c.3572C>T), located in coding exon 32 of the IKBKAP gene, results from a C to T substitution at nucleotide position 3572. The amino acid change results in alanine to valine at codon 1191, an amino acid with similar properties. However, this change occurs in the last base pair of coding exon 32, which makes it likely to have some effect on normal mRNA splicing. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005042844 | SCV005674473 | uncertain significance | Medulloblastoma; Familial dysautonomia | 2024-06-14 | criteria provided, single submitter | clinical testing |